Research Article

Anatomical Resection Improved the Outcome of Intrahepatic Cholangiocarcinoma: A Propensity Score Matching Analysis of a Retrospective Cohort

Table 4

Univariate and multivariate analyses of relative risk of overall survival in the PSM cohort.

VariablesUnivariate analysisMultivariate analysis
HR (95%CI)HR (95%CI)

Group (NAR vs. AR)0.661 (0.460–0.949)0.0250.655 (0.448–0.958)0.029
Age (year) (≤60 vs. >60)1.089 (0.748–1.585)0.657
Sex (female vs. male)0.921 (0.641–1.323)0.655
HBV infection (no vs. yes)0.820 (0.527–1.275)0.378
Smoke history (no vs. yes)0.913 (0.613–1.359)0.652
Alcohol history (no vs. yes)0.959 (0.587–1.567)0.868
Child–Pugh classification (A vs. B)0.832 (0.467–1.482)0.533
ALT (U/L) (≤40 vs. >40)0.809 (0.517–1.265)0.352
AST (U/L) (≤40 vs. >40)1.040 (0.678–1.598)0.856
ALB (g/L) (≤35 vs. >35)0.651 (0.409–1.036)0.070
TB (μmol/L) (≤20.5 vs. >20.5)1.123 (0.731–1.725)0.596
CA19-9 (U/mL) (≤37 vs. >37)1.273 (0.890–1.822)0.186
CEA (ng/mL) (≤20 vs. >20)0.849 (0.414–1.740)0.654
AFP (ng/mL) (≤40 vs. >40)0.668 (0.211–2.108)0.491
Cirrhosis (no vs. yes)1.087 (0.684–1.728)0.724
Laparoscopic approach (no vs. yes)0.618 (0.378–1.011)0.055
Robotic approach (no vs. yes)0.547 (0.174–1.722)0.302
Portal vein occlusion (no vs. yes)1.325 (0.919–1.909)0.131
IVC occlusion (no vs. yes)0.999 (0.440–2.272)0.999
Intraoperative transfusion (no vs. yes)1.577 (0.867–2.869)0.136
Conversion to open surgery (no vs. yes)1.086 (0.568–2.075)0.804
Tumor size (cm) (≤5 vs. >5)2.399 (1.666–3.453)<0.0012.050 (1.393–3.018)<0.001
Tumor number (singular vs. multiple)2.573 (1.754–3.775)<0.0011.962 (1.281–3.006)0.002
Differentiation (poor vs. well/moderate)0.323 (0.213–0.489)<0.0010.399 (0.261–0.609)<0.001
Lymph node metastasis (no vs. yes)1.759 (1.193–2.593)0.0040.983 (0.629–1.537)0.942
Neuron invasion (no vs. yes)0.552 (0.175–1.738)0.310
Necrosis in pathology (no vs. yes)2.568 (0.941–7.006)0.065
PVTT in pathology (no vs. yes)2.198 (0.891–5.418)0.087
Microvascular invasion (no vs. yes)1.725 (0.967–3.075)0.065